French biotech stock soars 34% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
原文: https://www.cnbc.com/2026/06/30/abivax-stock-trial-data-biotech-obefazimod.html
Last Update:
30 6 月, 2026
